Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase.

The Journal of Experimental Medicine
D T Fearon, K F Austen

Abstract

A function of P in the alternative complement pathway is to prolong the first order decay of the hemolytic sites on EAC43B in a dose-dependent manner. As the number of initial convertase sites is not changed, even when activated properdin (P) increases the t1/2 10-fold or more, P acts to stabilize rather than to uncover additional sites. P binds to EAC43 to generate EAC43P in a reaction that proceeds slightly more rapidly at 15 degrees C than at 0 degrees C, but reaches the same plateau and does not require divalent cations. The presence of P on EAC43P not only stabilizes the convertase subsequently formed on that cell, but, alternatively, permits transfer to convertase sites on other cells with the stability of the recipient intermediate being dependent on the P available for transfer. The capacity of P to bind to C3b and stabilize C3B contrasts with the inhibitory effect of the C3b inactivator on formation of this amplification convertase.

References

Apr 1, 1972·The Journal of Experimental Medicine·H J Müller-Eberhard, O Götze
Aug 1, 1974·The Journal of Experimental Medicine·D T FearonS Ruddy
Oct 1, 1972·Proceedings of the National Academy of Sciences of the United States of America·C A AlperP J Lachmann
Jan 1, 1973·The Journal of Immunology : Official Journal of the American Association of Immunologists·L G HunsickerK F Austen
Jan 1, 1974·The Journal of Experimental Medicine·O Götze, H J Müller-Eberhard
Feb 1, 1974·The Journal of Experimental Medicine·D T FearonS Ruddy
Aug 1, 1965·The Journal of Experimental Medicine·U R NILSSON, H J MUELLER-EBERHARD

❮ Previous
Next ❯

Citations

Jan 1, 1984·Springer Seminars in Immunopathology·M K Pangburn, H J Müller-Eberhard
Jan 1, 1993·Immunologic Research·K K Maves, J M Weiler
Jan 1, 1993·Immunologic Research·J FigueroaP Densen
Jan 1, 1989·Immunologic Research·J M Weiler
Jan 1, 1978·Journal of Immunological Methods·J O Minta, W Vetvutanapibul
Jan 1, 1981·Journal of Immunological Methods·B W Needleman, J M Weiler
Jul 16, 1985·Journal of Immunological Methods·A Lundwall, G Eggertsen
Jun 10, 1986·Journal of Immunological Methods·Y NakanoM Tomita
Oct 4, 1990·Journal of Immunological Methods·R E EdensJ M Weiler
Feb 26, 1993·Journal of Immunological Methods·J SeinoM R Daha
Jan 1, 1985·Biomaterials·M MauzacM D Kazatchkine
Jan 1, 1980·Comparative Immunology, Microbiology and Infectious Diseases·H W Renshaw, R J Gilmore
Apr 1, 1982·Molecular Immunology·R G Discipio
Oct 1, 1984·Molecular Immunology·D B Blanchard, R W Leid
May 1, 1985·Molecular Immunology·J CookM D Kazatchkine
Apr 1, 1991·Molecular Immunology·Z Fishelson
Apr 1, 1985·Immunopharmacology·M D SharathJ M Weiler
Sep 1, 1992·Immunopharmacology·M OppermannO Götze
May 30, 2002·Biomaterials·Johan Benesch, Pentti Tengvall
Mar 4, 2000·Molecular Immunology·C A FijenE J Kuijper
Aug 22, 2001·Biochimica Et Biophysica Acta·M V PerdikoulisK B Reid
Aug 20, 2010·Nature Immunology·Daniel RicklinJohn D Lambris
Aug 9, 2005·Nature Immunology·Suzan H M RooijakkersJos A G van Strijp
Feb 26, 1976·The New England Journal of Medicine·D T Fearon
Oct 27, 2010·Proceedings of the National Academy of Sciences of the United States of America·Xiaobo WuJohn P Atkinson
Feb 7, 2012·Proceedings of the National Academy of Sciences of the United States of America·Hui-Fang ZhouChristine T N Pham
Feb 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·R G MedicusH J Müller-Eberhard
Sep 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·J M WeilerD T Fearon
Apr 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·D T Fearon, K F Austen
Dec 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·U E NydeggerK F Austen
Apr 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·D T Fearon
Aug 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·J K CzopK F Austen
Nov 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·D T Fearon
Jan 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·J G SissonsR D Schreiber

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Immunology : Official Journal of the American Association of Immunologists
L G HunsickerK F Austen
Proceedings of the National Academy of Sciences of the United States of America
J M WeilerD T Fearon
Proceedings of the National Academy of Sciences of the United States of America
D T Fearon, K F Austen
© 2022 Meta ULC. All rights reserved